Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States gptkb:FDA 2017 |
| gptkbp:ATCCode |
L01XC02
|
| gptkbp:biosimilar |
gptkb:Rituxan
|
| gptkbp:brand |
gptkb:Truxima
|
| gptkbp:drugClass |
antineoplastic agent
immunosuppressant |
| gptkbp:genericName |
rituximab-abbs
|
| https://www.w3.org/2000/01/rdf-schema#label |
Truxima
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Celltrion
|
| gptkbp:mechanismOfAction |
binds CD20 antigen on B lymphocytes
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea fatigue infections chills neutropenia infusion reactions |
| gptkbp:target |
gptkb:CD20
|
| gptkbp:usedFor |
gptkb:granulomatosis_with_polyangiitis
leukemia chronic lymphocytic leukemia rheumatoid arthritis microscopic polyangiitis |
| gptkbp:bfsParent |
gptkb:Celltrion
|
| gptkbp:bfsLayer |
7
|